Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

CJC-1295 No-Dac

£18.74£224.30

Buy CJC-1295 No Dac Peptide Vial

CJC 1295 without DAC, a widely known Growth Hormone Releasing Peptide (GHRP), is a peptide hormone made of amino acid. Studies have shown CJC-1295 no DAC can increase lean muscle mass, boost muscle strength, and reduce body fat.

Save 15% with our bulk buy packs (CJC-1295 No Dac x 4 Vials)

Buy 10 and get 10% Discount

443 in stock

Description

Buy CJC-1295 No DAC Peptide Vial

This product is intended for research purposes only. To be used by trained professionals only.

CJC-1295 No DAC (without Drug Affinity Complex) is a synthetic peptide that belongs to the class of growth hormone-releasing hormones (GHRH). It is designed to increase the secretion of growth hormone from the pituitary gland by stimulating its receptors, thereby enhancing endogenous growth hormone levels in the body.

The lack of DAC in its composition sets it apart from its counterpart, CJC-1295 with DAC, resulting in a shorter half-life. CJC-1295 No DAC comes in vials of different concentrations, namely 2mg, 5mg, and 10mg, offering researchers flexible dosing options for their experiments.

It has gained attention in the research community for its potential applications in muscle growth, fat loss, metabolic health, making it a valuable subject for further investigation in the fields of endocrinology and sports medicine.

Shop the full the range of CJC-1295 NO Dac peptide here, including learning more about the research, benefits and side effects associated with the peptide.


Key Features of CJC-1295 No DAC Vial (2mg, 5mg, 10mg)

  • Synthetic Peptide: Belongs to the growth hormone-releasing hormone (GHRH) class.
  • Mechanism of Action: Increases growth hormone secretion from the pituitary gland by stimulating its receptors.
  • Shorter Half-Life: The absence of DAC results in a shorter pharmacokinetic profile compared to CJC-1295 with DAC.
  • Available Concentrations: Offered in 2mg, 5mg, and 10mg vials, allowing for tailored dosing for research purposes.
  • Research Applications: Investigated for potential benefits in muscle growth, body composition enhancement, and metabolic health.
  • Endocrinology Focus: Valuable for studies within the fields of endocrinology and sports medicine.
  • Regulatory Status: Designed for research use only, not for human consumption.

Shop ALL peptide vials available from Direct Peptides Oceania.

Shipping and Handling

Shipping and handling of CJC-1295 No DAC Vial (2mg, 5mg, 10mg) are conducted with strict adherence to regulatory guidelines, ensuring that the peptides are securely packaged and transported under appropriate temperature controls to maintain their integrity and efficacy for research purposes.

Storage Guidelines

CJC-1295 No DAC should be stored at a temperature of -20°C to -80°C to ensure the stability and effectiveness of the peptide, protecting it from light and moisture until it is ready for use in research applications.


Reconstitution of CJC-1295 No DAC Vial (2mg, 5mg, 10mg)

To properly reconstitute CJC-1295 No DAC and maintain its effectiveness, first check the vial for any damage or contamination. Use a sterile diluent, such as bacteriostatic water or saline, and gently mix the solution by swirling the vial, avoiding vigorous shaking, and let it sit if necessary. Discover a full list of peptide supplies for reconstitution here.

Once reconstituted, refrigerate the peptide and discard any unused portion after 30 days to avoid degradation. Remember, proper handling and aseptic techniques are key to its efficacy.

CJC 1295 without DAC, or MOD GRF 1-29, is a variant of GRF 1-29, offering a slightly lower GH pulse compared to CJC 1295 with DAC. It’s commonly used alongside other GHRPs, and Direct Peptides Oceania offers a variety of peptide blends for research on their website.


References:

[1] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, L A Frohman (2006) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

[2] M Alba, D Fintini, A Sagazio, B Lawrence, JP Castaigne, L A Frohman, and R Salvatori (2006) Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse – American Journal of Physiology, Endocrinology and Metabolism, Volume 291, Issue 6, December 2006, Pages E1290-E1294.

Research use only. Not for human or animal consumption!


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Oceania Direct Peptides website: https://oceania.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


Buy CJC-1295 No DAC peptide vial online today from Oceania Direct Peptides 

You may also like…